Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03172065Phase 4Completed
Phase 4, randomised, double-blind trial of dexmedetomidine, sponsored by Assiut University. Primary endpoint: Occurrence of shoulder tip pain at 48 hours. Started Jul 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03172065.